Ameliorating Effects and Mechanisms of TaVNS on Constipation in PD Patients.

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 30, 2024

Conditions
Parkinson Disease, IdiopathicConstipation
Interventions
DEVICE

active Transcutaneous auricular vagus nerve stimulation

Transcutaneous auricular vagus nerve stimulation was conducted by transcutaneous electrical stimulation therapy instrument to the cymba conchae of left ear in the vicinity of the auricular branch vagus nerve. Stimulation parameters: frequency = 20 Hz; pulse width = 500 μs, twice a day, 30 minutes each time.

DEVICE

sham Transcutaneous auricular vagus nerve stimulation

In the sham stimulation group, the electrodes were fixed at the left earlobe with the same stimulus parameters. Stimulation parameters: frequency = 20 Hz; pulse width = 500 μs, twice a day, 30 minutes each time.

All Listed Sponsors
lead

Kezhong Zhang

OTHER

NCT06623591 - Ameliorating Effects and Mechanisms of TaVNS on Constipation in PD Patients. | Biotech Hunter | Biotech Hunter